Molina-Carballo, AntonioCubero-Millán, IsabelFernández-López, LuisaCheca-Ros, AnaMachado-Casas, IreneJerez-Calero, AntonioBlanca-Jover, EnriqueCantarero-Malagón, Antonio-ManuelUberos, JoséMuñoz-Hoyos, Antonio2023-02-092023-02-092021-06-17http://hdl.handle.net/10668/18046The kynurenine pathway of tryptophan metabolism has been involved in ADHD We quantified basal levels and daily fluctuations of tryptophan and several kynurenine metabolites, as well as their changes after treatment with methylphenidate (MPH). A total of 179 children were recruited, grouped into ADHD (n = 130) and healthy controls (CG,n = 49). Blood samples were drawn at 20:00 and 09:00 h and only in the ADHD group after 4.63±2.3 months of treatment. Nocturnal urine was collected between both draws. Factorial analysis (Stata12.0) was performed with Groups, Time, Hour of Day and Depressive Symptoms (DS) as factors. MPH significantly increased plasma Kynurenic acid (2.4 ± 1.03/2.78±1.3 ng/mL; baseline/post-treatment, morning; z = 1.96,penAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/ADHDChildrenDaily rhythmsDepressive symptomsKynureninesAttention Deficit Disorder with HyperactivityCentral Nervous System StimulantsChildHumansKynurenic AcidKynurenineMethylphenidateTryptophanresearch article34175711open access10.1016/j.psychres.2021.1140601872-7123https://doi.org/10.1016/j.psychres.2021.114060